LUIS MIGUEL CALLOL SÁNCHEZ-rekin lankidetzan egindako argitalpenak (8)

2008

  1. Efecto de AM3 en la calidad de vida de pacientes con enfermedad pulmonar obstructiva crónica en subgrupos de riesgo

    Medicina Clinica, Vol. 130, Núm. 18, pp. 688-692

2005

  1. Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD

    Chest, Vol. 127, Núm. 4, pp. 1212-1218

2001

  1. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón)

    American Journal of Respiratory and Critical Care Medicine, Vol. 163, Núm. 7, pp. 1578-1583

2000

  1. An evaluation of tissue polypeptide antigen (TPA) in the two bronchoalveolar lavage fractions of lung cancer patients

    Japanese Journal of Clinical Oncology, Vol. 30, Núm. 5, pp. 215-220

1995

  1. Carcinoembryonic antigen in the diagnosis of lung cancer using bronchoalveolar lavage: A comparative study with healthy subjects, chronic bronchitis, respiratory infections and interstitial pulmonary diseases

    International Journal of Oncology, Vol. 6, Núm. 5, pp. 1093-1098

  2. Cytologic and biochemical component in 203 bronchoalveolar lavages. Reference values

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 12, Núm. 1, pp. 3-11

1994

  1. Calcitonin in broncho-alveolar lavage of malignant and non-malignant pulmonary diseases [3]

    International Journal of Biological Markers

1989

  1. Tumour markers in broncho-alveolar lavage

    Acta Oncologica, Vol. 28, Núm. 2, pp. 290-291